Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Zepbound is used along with a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of: 30 kg/m^2 or greater (obesity) or 27 kg/m^2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea, or cardiovascular disease)
Epidemiologic studies have shown a link between vitamin B12 and folate deficiencies and increased metabolic risk
The combined effect is sustainable and safe weight loss for people who take a GLP-1 agonist medication under medical supervision, according to a clinical review of GLP-1 receptor agonists published in Drugs in Context
In MASLD, oxidative stress, particularly associated with hepatic steatosis, triggers the activation of the NLRP3 inflammasome [185]
The key challenge is maintaining adequate nutrition despite reduced appetite
Over the forecast period from 2025 to 2034
